Aspire Private Capital’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Aspire Private Capital’s Portfolio GMDA Stock Details GMDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-200	Closed	-$7	–	756
2024 Q1	$7	Hold	200	–	–	﹤0.01%	721
2023 Q4	$82	Hold	200	–	–	﹤0.01%	688
2023 Q3	$206	Hold	200	–	–	﹤0.01%	670
2023 Q2	$386	Hold	200	–	–	﹤0.01%	621
2023 Q1	$162	Hold	200	–	–	﹤0.01%	632
2022 Q4	$258	Hold	200	–	–	﹤0.01%	618
2022 Q3	$0	Hold	200	–	–	﹤0.01%	677
2022 Q2	$0	Buy	+200	New	+$508	﹤0.01%	651

Other funds holding GMDA

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Aspire Private Capital's GMDA Position: Q2 2024 in Review

Aspire Private Capital sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q2 2024, closing a stake of 200 shares — an estimated $7 sold.

Aspire Private Capital first reported a position in GMDA in Q2 2022 and held it in 8 quarters. The position peaked at $386 in Q2 2023. 2 funds tracked by Wall St. Rank hold GMDA as of Q2 2024.

Aspire Private Capital reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q2 2024 after selling out during the quarter.
Aspire Private Capital sold 200 Gamida Cell Ltd. Ordinary Shares shares in Q2 2024, an estimated $7.
Aspire Private Capital first reported a position in Gamida Cell Ltd. Ordinary Shares in Q2 2022 and held it in 8 quarters.
Aspire Private Capital's Gamida Cell Ltd. Ordinary Shares position peaked at $386 in Q2 2023.
2 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q2 2024.

Based on Aspire Private Capital's 13F filing for Q2 2024, filed 15 Jul 2024.